GAMA
BMY icon

Graticule Asia Macro Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Graticule Asia Macro Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-161,000
Closed -$8.97M – 89
2017
Q2 		$8.97M Buy
+161,000
New +$8.76M 0.43% 46

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Graticule Asia Macro Advisors's BMY Position: Q4 2018 in Review

Graticule Asia Macro Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 12,600 shares — an estimated $782K sold.

Graticule Asia Macro Advisors first reported a position in BMY in Q3 2015 and held it in 5 quarters. The position peaked at $9.32M in Q4 2016. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • Graticule Asia Macro Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 12,600 Bristol-Myers Squibb shares in Q4 2018, an estimated $782K.
  • Graticule Asia Macro Advisors first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 5 quarters.
  • Graticule Asia Macro Advisors's Bristol-Myers Squibb position peaked at $9.32M in Q4 2016.
  • 1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.